Apr 30, 2026 12:22PM
Apr 30, 2026 07:13AM
Mar 2, 2026 07:04AM
Feb 26, 2026 07:01AM
Feb 12, 2026 07:12AM
Feb 5, 2026 02:31PM
Jan 30, 2026 08:24AM Piper Sandler Reiterates Overweight Rating on NovoCure Ltd. (NVCR)
Jan 13, 2026 06:42AM
Jan 12, 2026 07:01AM
Dec 2, 2025 06:41AM
Oct 30, 2025 07:05AM
Oct 15, 2025 07:00AM
Sep 30, 2025 06:51AM
Sep 15, 2025 07:02AM NovoCure's Optune Lua receives approval in Japan for lung cancer treatment
Aug 28, 2025 07:18AM
Aug 25, 2025 07:00AM
Aug 20, 2025 07:01AM
Jul 25, 2025 06:39AM
Jul 24, 2025 07:01AM
Jul 8, 2025 07:34AM
Jul 3, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on NovoCure Ltd. (NVCR)
Jun 2, 2025 06:46AM
May 30, 2025 08:34AM
Apr 25, 2025 06:54AM
Apr 24, 2025 07:04AM
Apr 22, 2025 07:12AM
Feb 27, 2025 07:06AM
Jan 13, 2025 07:06AM Novocure (NVCR) Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
Dec 19, 2024 08:17AM
Dec 13, 2024 07:33AM
Dec 3, 2024 06:44AM
Dec 2, 2024 07:03AM
Dec 2, 2024 07:01AM
Dec 2, 2024 06:00AM
Nov 21, 2024 07:01AM Novocure (NVCR): FDA Approves Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Oct 31, 2024 07:59AM
Oct 30, 2024 07:12AM
Oct 30, 2024 07:02AM
Oct 16, 2024 06:06AM
Oct 15, 2024 04:44PM
Oct 15, 2024 04:36PM
Oct 15, 2024 04:09PM Novocure (NVCR): FDA Approves Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer
Sep 3, 2024 07:01AM
Jul 26, 2024 06:48AM
Jul 25, 2024 07:02AM

416,812 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All